Sarcopenia
Clinical reviewer: Jacob Moore, MD · Last checked September 24, 2026
What is sarcopenia?
Sarcopenia is a muscle disease marked by a loss of muscle strength, quantity, and quality that builds up over a lifetime. It is common in older adults but can also occur earlier in life. Poor physical performance is treated as a sign of a more severe form.
How is sarcopenia diagnosed?
Sarcopenia is defined as a muscle disease, sometimes called muscle failure, that results from adverse muscle changes accumulating over a lifetime; it is common in older adults but can occur earlier [1]. The current European consensus definition focuses on low muscle strength as the key sign, uses low muscle quantity or quality to confirm the diagnosis, and treats poor physical performance as a marker of severe sarcopenia [1].
Why does sarcopenia come up with GLP-1 weight loss in older adults?
A 2024 review notes that older age and disease severity may affect who is considered a good candidate for these therapies, given the risk of sarcopenia [2]. A 2026 review of 35 studies on incretin-based weight loss found that no study reported objective physical function outcomes, so those studies did not show how the drugs affect strength or function [3]. In a separate meta-analysis, adding resistance training to a lifestyle weight-loss plan produced the lowest lean-mass share of total weight lost, at 17.5% [4].
Related terms
Sources
- Sarcopenia, revised European consensus on definition and diagnosis.
- Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies.
- Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition, A Systematic Review.
- Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention, A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
This entry is for education and is not medical advice. Talk with a licensed clinician about your own situation before starting, stopping, or changing any treatment.
